Dow Chemical Co. et al. v. NOVA Chemicals Corp., (2016) 487 N.R. 230 (FCA)
Linked as:
Extract
Dow Chemical Co. et al. v. NOVA Chemicals Corp., (2016) 487 N.R. 230 (FCA)
No longer available (Autolink)
See the full content of this document
This document cites
- Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
- AstraZeneca Canada Inc. et al. v. Mylan Pharmaceuticals ULC et al., (2012) 432 N.R. 292 (FCA)
- Wenzel Downhole Tools Ltd. et al. v. National-Oilwell Canada Ltd. et al., (2012) 443 N.R. 173 (FCA)
- Fournier Pharma Inc. et al. v. Canada (Minister of Health) et al., (2012) 413 F.T.R. 277 (FC)
- Bayer Inc. et al. v. Cobalt Pharmaceuticals Co. et al., (2015) 474 N.R. 311 (FCA)